Pluristem Beings PAH Clinical Trial

Jeannine · Sep 11, 2009

PluristemBegins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease

http://www.reuters.com/article/pressRelease/idUS125367+10-Sep-2009+BW20090910

barbara · Sep 11, 2009

Just a reminder - Dr. Prather from Pluristem will be hosting the Ask the Doctor this month. Get your questions in to my e-mail now please.